Dorsey Wright & Associates Edwards Lifesciences Corp Transaction History

Dorsey Wright & Associates

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$78.68 - $90.67 $2.38 Million - $2.74 Million	-30,204 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$71.69 - $91.23 $192,989 - $245,591	2,692 Added 9.78%	30,204 $2.76 Million
Q3 2020 Oct 28, 2020	SELL	$67.19 - $87.44 $922,585 - $1.2 Million	-13,731 Reduced 33.29%	27,512 $2.2 Million
Q2 2020 Jul 23, 2020	BUY	$57.54 - $76.95 $2.37 Million - $3.17 Million	41,243 New	41,243 $2.85 Million
Q1 2020 Apr 20, 2020	SELL	$52.41 - $81.0 $473,681 - $732,078	-9,038 Closed	0 $0

Q4 2019 Jan 31, 2020	SELL	$71.7 - $82.09 $16,849 - $19,291	-235 Reduced 2.53%	9,038 $2.11 Million
Q3 2019 Oct 31, 2019	SELL	$61.55 - $75.43 $4,246 - $5,204	-69 Reduced 0.74%	9,273 $2.04 Million
Q2 2019 Jul 02, 2019	SELL	$55.74 - $64.41 $27,535 - $31,818	-494 Reduced 5.02%	9,342 $1.73 Million
Q1 2019 Apr 04, 2019	BUY	$47.89 - $64.05 $471,046 - $629,995	9,836 New	9,836 $1.88 Million

1,378

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.